Altimmune, Inc. - Common Stock, par value $0.0001 per share (ALT)
CUSIP: 02155H200
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 200,000,000
- Total 13F shares
- 1,281,842
- Share change
- +167,981
- Total reported value
- $2,423,890
- Put/Call ratio
- 0%
- Price per share
- $1.89
- Number of holders
- 21
- Value change
- +$314,812
- Number of buys
- 10
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 02155H200?
CUSIP 02155H200 identifies ALT - Altimmune, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 02155H200:
Top shareholders of ALT - Altimmune, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.27%
|
534,175
|
$1,042,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
86,175
|
$168,000 | — | 30 Sep 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
76,252
|
$149,000 | — | 30 Sep 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
65,964
|
$129,000 | — | 30 Sep 2019 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.03%
|
53,183
|
$104,000 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
43,615
|
$85,000 | — | 30 Sep 2019 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
41,758
|
$81,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
34,479
|
$67,000 | — | 30 Sep 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
30,434
|
$59,000 | — | 30 Sep 2019 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.01%
|
28,324
|
$55,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
25,034
|
$49,000 | — | 30 Sep 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
20,548
|
$40,000 | — | 30 Sep 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
17,024
|
$33,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
15,856
|
$31,000 | — | 30 Sep 2019 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
13,033
|
$25,000 | — | 30 Sep 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
11,248
|
$22,000 | — | 30 Sep 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
7,200
|
$14,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
5,803
|
$11,000 | — | 30 Sep 2019 | |
| CWM, LLC |
13F
|
Company |
0%
|
1,025
|
$10,000 | — | 30 Sep 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
2,325
|
$5,000 | — | 30 Sep 2019 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
1,000
|
$1,950 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
431
|
$1,000 | — | 30 Sep 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
355
|
$1,000 | — | 30 Sep 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
147
|
$1,000 | — | 30 Sep 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Sep 2019 |
Institutional Holders of Altimmune, Inc. - Common Stock, par value $0.0001 per share (ALT) as of Q4 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.